For research teamsHelp me find a study
Back to all studies
CompletedNCT04044664

Safety study of Safety and Efficacy of NYX-783 in PTSD

This study is completed in the United States. It is testing Safety and Efficacy of NYX-783 for PTSD.

PTSDDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Placebo oral capsule may be useful for adults experiencing ptsd.

What would participation involve?

Participants may receive Placebo oral capsule, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: January 25, 2019
Recruitment status
Completed
Enrollment listed in the registry
160
Sponsor
Aptinyx
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04044664
Official title
A Study to Evaluate the Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT04044664. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 37 sites
  • Aptinyx Clinical Site
    Tuscaloosa, Alabama
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Bellflower, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Glendale, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Imperial, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Oakland, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Orange, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Riverside, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    San Diego, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    San Marcos, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Temecula, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Torrance, California
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Colorado Springs, Colorado
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Norwich, Connecticut
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Aptinyx
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    New York, New York
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Salisbury, North Carolina
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Canton, Ohio
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Aptinyx Clinical Site
    Bellevue, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population. The study team can confirm the exact objective and what it means for you.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo oral capsule, NYX-783. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with ptsd; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Aptinyx, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
CompletedNCT01861847

7-Keto DHEA for PTSD

This study is completed. It focuses on PTSD and currently lists study information in the United States.

Drug study icon
CompletedNCT00554177

A study for PTSD

This study is completed. It focuses on PTSD and currently lists study information in the United States.